| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Senju Pharmaceutical Co., Ltd. last filed a Form 4 in January 2018, as 10% Owner at HYPD.
At the last filing, the largest reported position was 1,718,566 shares of HYPD. Net of sales, the HYPD filings show accumulation of 100,000 shares.
Senju Pharmaceutical Co., Ltd. has 1 Form 4 filing on record in January 2018, as 10% Owner at Hyperion Defi (HYPD), 2018.
The 1 reported transaction was 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $1.0M and no sales.
The only open-market purchase was 100,000 shares of HYPD at an average $10.00 on January 29, 2018, about $1.0M.
Shares as reported in the last Form 4 for each company; the most recent is from January 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2018 | HYPD Hyperion Defi, Inc. | 10% Owner | Buy | 100,000 | $10.00 | $1,000,000.00 | +6.2% |